Filter
1848
Filtered Results: 1848
Text search:
pharmaceutical
guidelines
Featured
Recommendations
178
New Publications
499
Language
Document type
No document type
972
Studies & Reports
315
Guidelines
310
Strategic & Response Plan
86
Manuals
85
Fact sheets
26
Training Material
24
Situation Updates
14
Resource Platforms
8
Infographics
4
Brochures
3
Online Courses
1
Countries / Regions
Kenya
78
India
77
Ethiopia
71
Global
54
South Africa
50
Nigeria
42
Western and Central Europe
41
Uganda
39
Sierra Leone
38
Liberia
36
Ghana
29
Namibia
29
Zambia
28
Rwanda
27
Tanzania
27
Nepal
26
Malawi
26
Africa
24
Ukraine
19
Philippines
19
Latin America and the Carribbean
19
Bangladesh
19
Zimbabwe
18
Eastern Europe
17
Lesotho
16
Cambodia
16
Indonesia
12
Botswana
11
Myanmar / Burma
11
Eswatini/ Swaziland
11
Syria
9
Germany
9
Congo, Democratic Republic of
9
South–East Asia Region
9
Eastern Europe and Central Asia
9
Asia
8
West and Central Africa
8
East and Southern Africa
8
Brazil
8
Russia
8
Senegal
7
Cameroon
6
Guinea
6
Thailand
5
Middle East and North Africa
5
South Sudan
5
Benin
4
Chile
4
Albania
4
Burkina Faso
4
Mozambique
4
Haiti
4
Western Pacific Region
4
Laos
3
USA
3
United Kingdom
3
Vietnam
3
Papua New Guinea
3
Sudan
3
Mali
3
Pakistan
3
Tajikistan
2
China
2
Fiji
2
Kyrgyzstan
2
Jordan
2
North America
2
Yemen
2
Iraq
2
North Macedonia
1
Timor Leste/ East Timor
1
Serbia
1
Australia
1
Kazakhstan
1
Iran
1
Niger
1
Uzbekistan
1
Afghanistan
1
Peru
1
Malaysia
1
Bulgaria
1
Armenia
1
Venezuela
1
Lithuania
1
Saudi Arabia
1
Gabon
1
Turkmenistan
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Argentina
1
Lebanon
1
Moldova
1
Egypt
1
Romania
1
Palestine
1
Georgia
1
Central African Republic
1
Angola
1
Somalia
1
Authors & Publishers
Publication Years
Category
Countries
795
Clinical Guidelines
137
Public Health
100
Key Resources
70
Women & Child Health
52
Pharmacy & Technologies
35
Capacity Building
14
Annual Report MEDBOX
2
Toolboxes
AMR
188
Pharmacy
177
COVID-19
136
TB
101
HIV
100
Mental Health
92
Rapid Response
57
NCDs
44
Caregiver
40
Planetary Health
40
NTDs
36
Ebola
28
Conflict
24
Global Health Education
20
Health Financing Toolbox
12
Disability
11
Polio
11
Specific Hazards
10
Refugee
7
Natural Hazards
7
Cholera
3
Social Ethics
3
Zika
3
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The increasing amounts of official development assistance (ODA) for health have been aimed primarily at fighting HIV/AIDS, malaria and tuberculosis. Neglected tropical diseases (NTD), one of the most serious public health burdens among the most deprived communities, have only recently drawn the atte...
This report analyses the intersection of HIV, COVID-19 and public debt in developing countries. The collision between COVID-19 and a crippling debt crisis have reversed decades of progress - putting present and future investments in health and HIV at risk. Pragmatic options to address the pandemic t...
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemic and Zika outbreak between 2014 and 2019 in order to understand the shortcomings in funding reporting...
I examine the effectiveness of donors in targeting the highest burden of malaria in the Democratic Republic of Congo when health information structure is fragmented. I exploit local variations in the burden of malaria induced by mining activities as well as financial and epidemiological data from he...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
The World Heart Federation (WHF) is a leading global advocate for stronger legislation and policies regarding cardiovascular disease (CVD) and its risk factors, including raised cholesterol. The present Cholesterol Advocacy Toolkit 2022 provides WHF member organizations with information as well as p...
Cardiovascular diseases, principally ischemic heart disease (IHD), are the most important cause of death and disability in the majority of low- and lower-middle-income countries (LLMICs). In these countries, IHD mortality rates are significantly greater in individuals of a low socioeconomic status (...
